Epidemiological profile of fungemia isolates at Mohammed VI university hospital, Marrakech

Invasive fungal infections (IFIs) are a major global health problem, especially among hospitalized and immunocompromised patients. Traditionally, critically ill ICU patients—those with invasive procedures, long hospital stays, abdominal surgery, neutropenia, or severe trauma—are the most affected. The global incidence of IFIs is rising, with over 300 million individuals affected and an estimated 1.5 million deaths annually Fungemia is defined as at least one positive blood culture for yeast or non-Aspergillus mold associated with clinical signs of infection. Yeasts are the main cause of fungemia, with Candida spp. being the most frequent agent. Increasingly, non-albicans Candida species—such as Nakaseomyces glabratus, C. tropicalis, and C. parapsilosis—are surpassing C. albicans in prevalence. The objective of our study is to determine the frequency of fungemia and describe its epidemiological characteristics at CHU Mohamed VI in Marrakech.